Physician profile
Tavin B Morgan
NPI 1255064424
$5,233.77
in general payments reported to CMS, 2019-2025
21 companies · $2,833 in 2025
The $2,833 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $467 · 2023: $1,115 · 2024: $818 · 2025: $2,833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,717 · Travel and Lodging: $2,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,717.39 |
| Travel and Lodging | $2,048.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $2,216.69 | 2025 | Truelok, Physio-Stim |
| Stryker Corporation | $904.43 | 2022-2025 | 7 X 23mm Citrelock Implant, Citrefix, Prostep Mica |
| Kerecis Limited | $392.70 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Ibsa Pharma INC. | $229.11 | 2023-2024 | Licart |
| Angiodynamics, INC. | $209.14 | 2025 | Auryon Laser System 100-120 Vac |
| Convatec INC. | $206.85 | 2023-2024 | |
| Bioventus LLC | $174.97 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Nevro Corp. | $168.85 | 2023 | Senza |
| Integra Lifesciences Corporation | $166.05 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Solventum Corporation | $125.80 | 2024-2025 | Activ.A.C., V.A.C.Ulta, V.A.C.Instill |
| Alexion Pharmaceuticals, INC. | $103.32 | 2024 | |
| Kci USA, INC. | $87.85 | 2022 | |
| Smith+Nephew, INC. | $86.98 | 2022-2025 | Collagenase Santyl |
| Musculoskeletal Transplant Foundation INC. | $45.29 | 2023 | |
| Eclipse Technology Solutions INC. | $23.20 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $18.55 | 2023 | Qutenza |
| Metric Medical Devices, INC. | $16.66 | 2023 | Super Scaffold, Super Staple |
| Tactile Systems Technology INC | $15.13 | 2024 | Flexitouch Plus, Entre Plus |
| Ultragenyx Pharmaceutical INC. | $14.67 | 2023 | Crysvita |
| Kowa Pharmaceuticals America, INC. | $14.39 | 2023 | Seglentis |
| Grt US Holding, INC. | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tavin Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.